Taiwan's plan to procure the oral antiviral drug, molnupiravir, remains unchanged, Health and Welfare Minister Chen Shih-chung (陳時中) said Saturday, although the drug has been shown to be less effective in reducing COVID-19 hospitalizations and deaths in its final analysis.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
District court again grants bail to ex-Taipei Mayor Ko Wen-je (update)
09/15/2025 09:27 PM - Politics
Guatemala celebrates Independence Day in Taiwan with reception, exhibit
09/15/2025 08:34 PM - Culture
In Ghost Festival event, Chiayi honors ghosts of all genders
09/15/2025 08:28 PM - Business
Alfa Romeo returns to Taiwan market
09/15/2025 07:56 PM - Business
Manufacturing sector's Q2 fixed asset investments up on IC expansion
09/15/2025 07:45 PM